Venture Capital
The new round brought AusperBio’s fundraising total since 2024 to over $340 million.
1
Biopharma firm AusperBio secures $120m Series C to advance chronic hepatitis B therapies
2
EV maker Omega Seiki raises $5.2m funding, and other India deals
3
Temasek defends SIA's Air India investment amid growing scrutiny
4
Editor's Take: The Week That Was—August 24-29
5
Danantara’s $18.6b profit claim puts disclosure in focus
More Stories
Editor’s Take: The Week That Was—August 24-29
Asia’s IPO revival opens new exit routes for LPs
Aura Group launches private equity, credit evergreen fund
KKR, IMM to invest $2.1b in SK Telecom’s AI data centre platform
Deals
Earlier this month, OSM had raised an equal amount from Securocorp Securities, others.
Air India has requested about $1.5b in fresh equity from owners Tata Sons and Singapore Airlines.
Analysis
Cutting-edge analyses, interviews, scoops and more in this edition.
These questions come when Danantara’s structure has expanded rapidly this year.
India
The nod from India’s market regulator comes as the country’s IPO market sees a revival.
Greater China
Shein first attempted to go public in New York and then in London.
The IPO market is reopening across multiple secular growth themes.
Indonesia
Electrum’s stronger performance came as TBS’s portfolio continued to move towards non-coal businesses.
LeapFrog’s existing investments in the country include Redcliffe Labs and Healthify.
